Clinical Trials Browser

Colonic Neoplasms, Neoplasm Metastasis, Colorectal Neoplasms

Parkinson Disease 4, Autosomal Dominant Lewy Body, Stomach Neoplasms

Breast Neoplasms

Breast Neoplasms

Pancreatic Intraductal Neoplasms

Rectal Neoplasms

Triple Negative Breast Neoplasms

Stomach Neoplasms

Breast Neoplasms

Esophageal Neoplasms, Neoplasm Metastasis, Neoplasms

Adenocarcinoma Of Esophagus, Stomach Neoplasms

Esophageal Squamous Cell Carcinoma

Breast Neoplasms

Neoplasms, Rectal Neoplasms

Colorectal Neoplasms

Colorectal Neoplasms

Breast Neoplasms

Rectal Neoplasms

Stomach Neoplasms

Rectal Neoplasms

Parkinson Disease 4, Autosomal Dominant Lewy Body, Nasopharyngeal Neoplasms

Breast Neoplasms

Parkinson Disease 4, Autosomal Dominant Lewy Body, Stomach Neoplasms

Colorectal Neoplasms

Neoplasm Metastasis, Colorectal Neoplasms

Nasopharyngeal Carcinoma

Breast Neoplasms

Stomach Neoplasms

Breast Neoplasms

Nasopharyngeal Carcinoma, Neoplasm Metastasis

Esophageal Neoplasms

Breast Neoplasms

Neoplasm Metastasis, Neoplasms

Breast Neoplasms

Parkinson Disease 4, Autosomal Dominant Lewy Body, Triple Negative Breast Neoplasms

Rectal Neoplasms

Stomach Neoplasms

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Metastatic Gastric Adenocarcinoma

HER2+ Metastatic Breast Cancer (MBC)

Rectal Neoplasms, Colorectal Neoplasms

Rectal Neoplasms, Colorectal Neoplasms

Rectal Neoplasms

Breast Neoplasms, Neoplasm Metastasis

Breast Neoplasms, Neoplasms

Stomach Neoplasms

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms, Triple Negative Breast Neoplasms

Colorectal Neoplasms

Clinical Trials

COLOCROSS

KEYNOTE-585

MECCA

DS-8201a in Pre-treated HER2 Breast Cancer That Cannot be Surgically Removed or Has Spread [DESTINY-Breast02]

Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery

GRECCAR8

IMpassion132

A Clinical Study To Evaluate Camrelizumab (SHR-1210) Plus Capecitabine and Oxaliplatin Followed by Sequential Treatment With Camrelizumab Plus Apatinib Mesylate in Advanced or Metastatic Gastric Cancer (GC) or Gastroesophageal Junction Cancer (GEJ) Without Prior Systemic Therapy

PRECIOUS

LOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus Lapatinib

CheckMate649

A Study of Tislelizumab (BGB-A317) in Combination With Chemotherapy as First Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma

TAC Versus TCX as Adjuvant Treatment for High-risk Her2-Negative Breast Cancer

Néofirinox

AIO-KRK-0114

LYNK-003

PEARL

GRECCAR12

Study of Adjuvant ONO-4538 With Resected Gastric Cancer

NACRE

Keynote-122

Efficacy and Safety of Trastuzumab Emtansine in Chinese Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Locally Advanced or Metastatic Breast Cancer

MK-3475-062

Safety and Efficacy Study of XELOX vs. Oxaliplatin+5-FU CI as First Line Treatment in Metastatic Colorectal Cancer

OBELICS

TPC vs PF as Induction Chemotherapy Combined With CCRT for Stage IVa-b Nasopharyngeal Carcinoma

Maintenance Treatment With Capecitabine Versus Observation in Breast Cancer Patients

Efficacy and Safety Evaluation of Sintilimab or Placebo in Combination With XELOX as First Line Treatment in Patients With Gastric Cancer

RIBBIT

Maintenance Capecitabine Plus Best Supportive Care Versus Best Supportive Care for Metastatic Nasopharyngeal Carcinoma

NEOadjuvant Trial in Adenocarcinoma of the oEsophagus and oesophagoGastric Junction International Study (Neo-AEGIS)

ASCENT

Avelumab in First-Line Maintenance Gastric Cancer (JAVELIN Gastric 100)

Trial of Vinflunine Plus Capecitabine in Advanced Breast Cancer

KEYNOTE-119

Preoperative Chemoradiotherapy and Transanal Endoscopic Microsurgery Versus Total Mesorectal Excision in T2-T3s N0, M0 Rectal Cancer

The Comparison of XELOX and EOX in the First-line Treatment of Advanced Gastric Cancer

Leucovorin and Fluorouracil With or Without Oxaliplatin Compared to Capecitabine With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer

RAINFALL

NALA

Radiation Therapy and Capecitabine With or Without Oxaliplatin in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Rectal Cancer

RectumSIB

Rektum-III

Novel Epothilone Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer

Epothilone (Ixabepilone) Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer

Chemotherapy Options for the First Line Chemotherapy in Elderly Patient With Advanced Gastric Cancer

SYSUCC-002

E7389 Versus Capecitabine in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With Anthracyclines and Taxanes

SYSUCC-001

A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer